366625
5-氟-2-甲基苯甲酸
99%
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
FC6H3(CH3)CO2H
化学文摘社编号:
分子量:
154.14
UNSPSC Code:
12352100
PubChem Substance ID:
MDL number:
Assay:
99%
InChI
1S/C8H7FO2/c1-5-2-3-6(9)4-7(5)8(10)11/h2-4H,1H3,(H,10,11)
SMILES string
Cc1ccc(F)cc1C(O)=O
InChI key
JVBLXLBINTYFPR-UHFFFAOYSA-N
assay
99%
mp
130-132 °C (lit.)
functional group
carboxylic acid, fluoro
Application
5-氟-2-甲基苯甲酸可用于制备：
- 5-氟-3-羟基-2-甲基苯甲酸
- 5-氟-2-甲基-3-硝基苯甲酸甲酯
- 5-氟-N，2-二甲基苯甲酰胺
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Multkilogram Scale-Up of a Reductive Alkylation Route to a Novel PARP Inhibitor.
Gillmore AT, et al.
Organic Process Research & Development, 16(12), 2063-2072 (1999)
E Takashiro et al.
Bioorganic & medicinal chemistry, 7(9), 2063-2072 (1999-10-26)
The structure-activity relationship of HIV-1 protease (HIV-1 PR) inhibitors containing alpha-hydroxy-beta-amino acids is discussed. We demonstrated that substituent groups on the P1 aromatic rings of the inhibitors exert significant influence on their biological activity. Inhibitors bearing an alkyl or a
Xing Fan et al.
Bioorganic & medicinal chemistry, 19(16), 4935-4952 (2011-07-23)
HIV-1 integrase (IN) is a validated therapeutic target for antiviral drug design. However, the emergence of viral strains resistant to clinically studied IN inhibitors demands the discovery of novel inhibitors that are structurally as well mechanistically different. Herein, we describe
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持